2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6153 | Icotinib | BPI-2009,BPI-2009H,Conmana | EGFR |
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity. | |||
T2307 | Icotinib Hydrochloride | BPI-2009H | EGFR |
Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type ... |